Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort ...
The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...
The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.
A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with ...
The second phase of Nintendo's game launch plan is then reportedly set for around October-November, and will have a greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results